(Q28194447)

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin intolerance and asthma. A clinical and immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin intolerance in asthma *1, *2Detection by oral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Oral Challenges to Detect Aspirin and Sulfite Sensitivity in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Idiosyncrasy to Pyrazolone Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

The diagnosis of aspirin idiosyncrasy by analgesic challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Hydrocortisone sodium succinate does not cross-react with aspirin in aspirin-sensitive patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Leukotrienes and slow reacting substance of anaphylaxis (SRS-A).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Aspirin-induced asthma: advances in pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Inhibition of monocyte leukotriene B production after aspirin desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Tryptase and histamine release during aspirin-induced respiratory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Effect of salicylates in urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Anaphylaxis. A review of 266 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Anaphylaxis to celecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Drug- and chemical-induced aseptic meningitis: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Pulmonary alveolitis and NSAIDs--fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Pulmonary infiltrates with eosinophilia due to naproxen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Pulmonary infiltrates associated with naproxen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia. Review of the literature and Food and Drug Administration Adverse Drug Reaction reports

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Naproxen and pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962099-6

7 January 2021

10.1016/S1081-1206(10)62099-6

Identifiers

DOI

0 references

Fatcat ID

release_dit27p6owvcsbougmlyo4ng6zq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dit27p6owvcsbougmlyo4ng6zq

24 November 2022